Division of Allergy Pulmonary and Critical Care Medicine

February 12, 2018

Protecting transplanted lungs

Acetaminophen may offer a simple treatment to prevent tissue injury following lung transplant, Vanderbilt researchers have discovered.

By Leigh MacMillan
February 1, 2018

Study tracks therapy to slow idiopathic pulmonary fibrosis

Investigators in the Division of Allergy, Pulmonary and Critical Care have launched a pilot study to see if patients with idiopathic pulmonary fibrosis (IPF) can tolerate the addition of a commonly used antiviral drug to standard IPF treatments. The research team believes the drug may ultimately help slow progression of the chronic and progressive disease or reverse its course.

By Nancy Humphrey
little girl using inhaler
January 4, 2018

Asthma study may point to potential new therapeutic approach

New findings from Vanderbilt suggest that blocking the migration of cells involved in asthma may represent a new approach for treating the respiratory condition.

By Leigh MacMillan
May 15, 2017

RSV-HRV viral interference

RSV infection reduces the risk of infection with human rhinovirus, which could have implications for vaccine development and prevention strategies for viral respiratory tract infections in infants.

By Leigh MacMillan
March 9, 2017

American Thoracic Society lauds Young’s contributions

Lisa Young, M.D., associate professor of Pediatrics and Medicine in the Divisions of Pulmonary Medicine and Allergy, Pulmonary, and Critical Care Medicine, has been selected to receive this year’s American Thoracic Society (ATS) Public Advisory Roundtable Excellence Award.

By Christina Echegaray
February 2, 2017

New Physician Science Doctoral Program graduates first student

As a fellow in pulmonary and critical care medicine at Vanderbilt University School of Medicine, Bradley Richmond, M.D., saw a lot of patients with chronic obstructive pulmonary disease (COPD), an inflammatory lung disease caused most often by long-term exposure to cigarette smoke.

By Bill Snyder
January 19, 2017

Study to track diabetes drug’s ability to also treat asthma

Investigators in the Division of Allergy, Pulmonary, and Critical Care Medicine and the Division of Diabetes, Endocrinology, and Metabolism recently received a $1.25 million grant from the National Institute of Allergy and Infectious Diseases.
By VUMC News and Communications
September 29, 2016

Childhood health influences focus of new NIH initiative

The National Institutes of Health (NIH) recently announced it will provide $157 million in awards to launch a multi-center, seven-year initiative that will investigate how exposure to environmental factors in early development — from conception through early childhood — influences the health of children and adolescents.
By Kathy Whitney
September 15, 2016

Grant spurs study of novel imaging technique for COPD

Vanderbilt researchers have received an R01 grant from the National Institutes of Health to study a novel non-invasive imaging approach to detect activation of inflammatory cells in the lungs of patients with chronic obstructive pulmonary disease (COPD), a progressive lung condition that makes breathing difficult.
By Kathy Whitney
September 1, 2016

Chance to help others drives neurosurgeon Thompson

The tears Reid Thompson, M.D., shed one day as a medical student left an indelible mark.
By Tom Wilemon
August 18, 2016

Major grant enhances pulmonary fibrosis research

Vanderbilt University Medical Center (VUMC) has received an $11 million program project renewal grant from the National Heart, Lung and Blood Institute to study the genetics and underlying biological mechanisms that lead to idiopathic pulmonary fibrosis (IPF).
By Kathy Whitney
July 21, 2016

Team to study RSV’s role in asthma formation

Investigators in the Division of Allergy, Pulmonary and Critical Care Medicine recently received a $4.5 million Asthma and Allergic Diseases Cooperative Research Center (AADCRC) grant from the National Institutes of Allergy and Infectious Diseases (NIAID).
By VUMC News and Communications
April 28, 2016

Study links COPD with increased bacterial invasion

Chronic obstructive pulmonary disease (COPD) is a common smoking-related lung illness and the third leading cause of death in the United States. Scientists have long believed that inhaling toxic gases and particles from tobacco smoke causes inflammation of the small airways in the lungs, leading to the development of COPD.
By VUMC News and Communications
1 … 7 8 9 10 11 12